Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$11.55
+7.04%
Mkt Cap $578.71M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 19, 2026 | $1.33M | $21.00K | -98.43% | -$0.45 | -$0.44 | +2.22% | — | — |
| Q4 2025 Nov 6, 2025 | $666.67K | $2.42M | +262.25% | -$0.60 | -$0.67 | -11.67% | — | — |
| Q3 2025 Aug 4, 2025 | $6.64M | $4.42M | -33.42% | -$1.11 | -$1.86 | -67.57% | — | — |
| Q2 2025 May 8, 2025 | $15.34M | $2.83M | -81.56% | -$0.92 | -$1.12 | -21.74% | — | — |
| Q1 2025 Feb 20, 2025 | $7.53M | $2.12M | -71.82% | -$1.02 | -$1.08 | -5.88% | — | — |
| Q4 2024 Nov 12, 2024 | $1.23M | $970.00K | -21.14% | -$1.18 | -$1.10 | +6.78% | — | — |
| Q3 2024 Aug 8, 2024 | $10.73M | $132.01M | +1130.33% | -$1.05 | $1.22 | +216.19% | — | — |
| Q2 2024 May 8, 2024 | $1.84M | $50.00K | -97.28% | -$1.21 | -$1.34 | -10.74% | — | — |
| Q1 2024 Feb 15, 2024 | $2.15M | $316.00K | -85.30% | -$1.23 | -$1.26 | -2.44% | — | — |
| Q4 2023 Nov 2, 2023 | $41.69M | $84.87M | +103.56% | -$0.32 | $0.38 | +218.75% | — | — |
| Q3 2023 Aug 3, 2023 | $4.52M | $4.02M | -11.08% | -$0.92 | -$1.03 | -11.96% | — | — |
| Q2 2023 May 4, 2023 | $4.52M | $2.17M | -52.01% | -$0.83 | -$0.89 | -7.23% | — | — |
| Q1 2023 Feb 23, 2023 | $7.37M | $49.92M | +577.38% | -$0.47 | $0.12 | +125.53% | — | — |
| Q4 2022 Nov 3, 2022 | $25.22M | $1.52M | -93.98% | -$0.31 | -$0.97 | -212.90% | — | — |
| Q3 2022 Aug 8, 2022 | $17.18M | $1.31M | -92.36% | -$0.51 | -$0.88 | -72.55% | — | — |
| Q2 2022 May 5, 2022 | $8.09M | $1.15M | -85.74% | -$0.85 | -$0.78 | +8.24% | — | — |
| Q1 2022 Feb 17, 2022 | $7.12M | $1.17M | -83.53% | -$0.74 | -$0.71 | +4.05% | — | — |
| Q4 2021 Nov 4, 2021 | $140.05M | $139.17M | -0.63% | $2.28 | $2.13 | -6.58% | — | — |
| Q3 2021 Aug 5, 2021 | $70.20M | $60.07M | -14.43% | $1.00 | $0.58 | -42.00% | — | — |
| Q2 2021 May 11, 2021 | $124.67K | $160.00K | +28.34% | -$0.80 | -$0.91 | -13.75% | — | — |